Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis

被引：0
|
作者：
Barbara Rossi
Giovanni Schinzari
Giulio Maccauro
Laura Scaramuzzo
Diego Signorelli
Michele A Rosa
Carlo Fabbriciani
Barone Carlo
机构：
[1] Catholic University,Department of Orthopaedics and Traumatology
[2] Agostino Gemelli Hospital,Department of Medical Oncology
[3] Catholic University,Department of Orthopaedics
[4] Agostino Gemelli Hospital,undefined
[5] Messina University,undefined
来源：
BMC Musculoskeletal Disorders | / 11卷
关键词：
Vascular Endothelial Growth Factor; Osteosarcoma; Vascular Endothelial Growth Factor Expression; Local Relapse; High Grade Osteosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] SARCOIDOSIS FOLLOWING ADJUVANT HIGH-DOSE METHOTREXATE THERAPY FOR OSTEOSARCOMA
    SYBERT, A
    BUTLER, TP
    ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) : 488 - 489
  • [32] PLASMA AND CSF METHOTREXATE LEVELS DURING HIGH-DOSE METHOTREXATE CHEMOTHERAPY
    GILCHRIST, NL
    CALDWELL, J
    WATSON, ID
    CUNNINGHAM, D
    FORREST, GJ
    SOUKOP, M
    BRITISH JOURNAL OF CANCER, 1985, 51 (04) : 590 - 590
  • [33] Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
    M P Michelagnoli
    I J Lewis
    H R Gattamaneni
    C C Bailey
    L S Lashford
    British Journal of Cancer, 1999, 79 : 1174 - 1178
  • [34] Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases:: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide
    Bacci, G
    Briccoli, A
    Ferrari, S
    Sæter, G
    Donati, D
    Longhi, A
    Manfrini, M
    Bertoni, F
    Rimondini, S
    Monti, C
    Forni, C
    ONCOLOGY REPORTS, 2000, 7 (02) : 339 - 346
  • [35] Perioperative chemotherapy with cisplatin (CP) and doxorubicin (DOX) with and without high-dose methotrexate (HDM) in adult osteosarcoma (AOT): Is methotrexate warranted?
    Da Silva Rocha, Lucila Soares
    Negrao, Marcelo Vailati
    Girardi, Daniel da Motta
    De Camargo, Veridiana Pires
    Valente Alban, Luciana Bastos
    Hoff, Paulo Marcelo
    Feher, Olavo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Relationship of Serum Methotrexate Concentration in High-Dose Methotrexate Chemotherapy to Prognosis and Tolerability: A Prospective Cohort Study in Chinese Adults With Osteosarcoma
    Lin, Feng
    Juan, Yue
    Zheng, Shui-Er
    Shen, Zan
    Tang, Li-Na
    Zhao, Hui
    Yao, Yang
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2009, 70 (02): : 150 - 160
  • [37] RAPID HIGH-DOSE INTENSITY CHEMOTHERAPY INCLUDING HIGH-DOSE MELPHALAN (HDM) FOR RHABDOMYOSARCOMA
    GROOTLOONEN, JJ
    PINKERTON, R
    MELLER, S
    MCELWAIN, TJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 430 - 430
  • [38] DEGRADATION AND CLEARANCE OF METHOTREXATE IN CHILDREN WITH OSTEOSARCOMA RECEIVING HIGH-DOSE INFUSION
    WANG, YM
    KIM, PY
    LANTIN, E
    VANEYS, DC
    ROMSDAHL, MM
    SUTOW, WW
    MEDICAL AND PEDIATRIC ONCOLOGY, 1978, 4 (03): : 221 - 229
  • [39] Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
    Zhang, Wei
    Zhang, Qing
    Zheng, Ting-Ting
    Zhen, Jian-Cun
    Niu, Xiao-Hui
    CHINESE MEDICAL JOURNAL, 2016, 129 (21) : 2530 - 2534
  • [40] Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma
    Abe, Kentaro
    Maeda-Minami, Ayako
    Ishizu, Taku
    Iwata, Shintaro
    Kobayashi, Eisuke
    Shimoi, Tatsunori
    Kawano, Yohei
    Hashimoto, Hironobu
    Yamaguchi, Masakazu
    Furukawa, Tetsuya
    Miyazaki, Satoru
    Mano, Yasunari
    ANTICANCER RESEARCH, 2022, 42 (02) : 1043 - 1050
12345